On October 31, 2024, the European Commission issued a fine of €462.6 million to Teva Pharmaceuticals, citing abuse of its ...

The vast majority of the would-be commissioners come from the right of the political spectrum, mostly the European People’s ...

The European Commission has hit the world's largest maker of generic drugs with a €462.6 million fine for breaching the ...

Yesterday, the European Commission fined the Israeli pharmaceutical group Teva 426.6 million euros for what it said was “abuse of a dominant position” for its drug against multiple sclerosis, Copaxone ...

The European Commission (EC) has fined pharmaceutical company Teva €462.6 million for “systematically spread[ing] misleading ...

The EU on Thursday slapped the world's largest generic drugmaker Teva with a 462.6-million-euro ($502 million) fine for "abusing its dominant position" to impede competition for its blockbuster ...

In a decisive move, the European Union’s antitrust authority fined Teva Pharmaceutical Industries €463 million ($502 million) ...

Teva Pharmaceuticals is being fined $503 million (€463 million) by the European Commission for delaying competition posed by ...

Pharmaceuticals Industries is responding to the European Decision following its investigation into the company’s practices ...

Teva Pharmaceuticals is being fined $503 million (€463 million) by the European Commission for delaying competition posed by ...

The European Commission has fined Israeli generic drugmaker Teva over 460 million euros for misuse of the patent system to prolong protection of its multiple sclerosis drug, Copaxone. Teva is accused ...